⌘K

Login Start Free

Home/Filings/4/0001424411-08-000058

4//SEC Filing

KASH PETER M 4

Accession 0001424411-08-000058

CIK 0001133869other

View on SEC.gov Company Profile

Filed

Dec 22, 7:00 PM ET

Accepted

Dec 23, 8:42 PM ET

Size

5.7 KB

Accession

0001424411-08-000058

Insider Transaction Report

Form 4

Period: 2008-12-23

Nile Therapeutics, Inc.NLTX

Director

Transactions

Award
Non-Qualified Stock Option (right to buy)
2008-12-23+35,000→ 35,000 total
Exercise: $0.93Exp: 2018-12-22→ Common Stock (35,000 underlying)

Footnotes (1)

[F1]100% of the shares subject to the option shall vest and become exercisable on January 1, 2010.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Nile Therapeutics, Inc.

CIK 0001133869

Entity typeother

Related Parties

1

filerCIK 0001253023

Filing Metadata

Form type: 4
Filed: Dec 22, 7:00 PM ET
Accepted: Dec 23, 8:42 PM ET
Size: 5.7 KB

View on SEC.gov